nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Infusion site reaction—Docetaxel—melanoma	0.0185	0.0418	CcSEcCtD
Treprostinil—Induration—Bleomycin—melanoma	0.0114	0.0258	CcSEcCtD
Treprostinil—Pain in extremity—Vemurafenib—melanoma	0.00612	0.0138	CcSEcCtD
Treprostinil—Wheezing—Bleomycin—melanoma	0.00496	0.0112	CcSEcCtD
Treprostinil—Viral infection—Temozolomide—melanoma	0.00477	0.0108	CcSEcCtD
Treprostinil—Neck pain—Carmustine—melanoma	0.00451	0.0102	CcSEcCtD
Treprostinil—Pulmonary embolism—Carmustine—melanoma	0.00446	0.0101	CcSEcCtD
Treprostinil—Pulmonary embolism—Temozolomide—melanoma	0.00431	0.00972	CcSEcCtD
Treprostinil—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00424	0.00957	CcSEcCtD
Treprostinil—Laryngeal pain—Docetaxel—melanoma	0.0042	0.00948	CcSEcCtD
Treprostinil—Oedema peripheral—Vemurafenib—melanoma	0.00417	0.00941	CcSEcCtD
Treprostinil—Sepsis—Dactinomycin—melanoma	0.00413	0.00932	CcSEcCtD
Treprostinil—Sepsis—Carmustine—melanoma	0.00387	0.00873	CcSEcCtD
Treprostinil—Thrombophlebitis—Carmustine—melanoma	0.00374	0.00843	CcSEcCtD
Treprostinil—Erythema—Vemurafenib—melanoma	0.00369	0.00831	CcSEcCtD
Treprostinil—Thrombophlebitis—Temozolomide—melanoma	0.00361	0.00815	CcSEcCtD
Treprostinil—Back pain—Vemurafenib—melanoma	0.00357	0.00804	CcSEcCtD
Treprostinil—Cough—Vemurafenib—melanoma	0.00322	0.00725	CcSEcCtD
Treprostinil—Arthralgia—Vemurafenib—melanoma	0.00314	0.00708	CcSEcCtD
Treprostinil—Myalgia—Vemurafenib—melanoma	0.00314	0.00708	CcSEcCtD
Treprostinil—Bone pain—Docetaxel—melanoma	0.00299	0.00675	CcSEcCtD
Treprostinil—Infection—Vemurafenib—melanoma	0.00299	0.00674	CcSEcCtD
Treprostinil—Hypokalaemia—Carmustine—melanoma	0.00295	0.00664	CcSEcCtD
Treprostinil—Dehydration—Temozolomide—melanoma	0.00291	0.00656	CcSEcCtD
Treprostinil—Pneumonia—Bleomycin—melanoma	0.00287	0.00648	CcSEcCtD
Treprostinil—Pulmonary embolism—Docetaxel—melanoma	0.00287	0.00646	CcSEcCtD
Treprostinil—Hypokalaemia—Temozolomide—melanoma	0.00285	0.00642	CcSEcCtD
Treprostinil—Hypotension—Vemurafenib—melanoma	0.00281	0.00634	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00274	0.00618	CcSEcCtD
Treprostinil—Haematuria—Bleomycin—melanoma	0.00272	0.00615	CcSEcCtD
Treprostinil—Pneumonia—Dactinomycin—melanoma	0.00268	0.00605	CcSEcCtD
Treprostinil—Decreased appetite—Vemurafenib—melanoma	0.00261	0.0059	CcSEcCtD
Treprostinil—Bronchitis—Temozolomide—melanoma	0.0026	0.00586	CcSEcCtD
Treprostinil—Fatigue—Vemurafenib—melanoma	0.00259	0.00585	CcSEcCtD
Treprostinil—Haemoglobin—Bleomycin—melanoma	0.00258	0.00582	CcSEcCtD
Treprostinil—Haemorrhage—Bleomycin—melanoma	0.00257	0.00579	CcSEcCtD
Treprostinil—Pneumonia—Carmustine—melanoma	0.00251	0.00566	CcSEcCtD
Treprostinil—Depression—Carmustine—melanoma	0.00249	0.00561	CcSEcCtD
Treprostinil—Sepsis—Docetaxel—melanoma	0.00249	0.00561	CcSEcCtD
Treprostinil—Urinary tract infection—Carmustine—melanoma	0.00242	0.00547	CcSEcCtD
Treprostinil—Pneumonia—Temozolomide—melanoma	0.00242	0.00547	CcSEcCtD
Treprostinil—Depression—Temozolomide—melanoma	0.0024	0.00542	CcSEcCtD
Treprostinil—Thrombophlebitis—Docetaxel—melanoma	0.0024	0.00542	CcSEcCtD
Treprostinil—Flushing—Bleomycin—melanoma	0.00238	0.00537	CcSEcCtD
Treprostinil—Body temperature increased—Vemurafenib—melanoma	0.00238	0.00536	CcSEcCtD
Treprostinil—Pharyngitis—Dactinomycin—melanoma	0.00237	0.00536	CcSEcCtD
Treprostinil—Urinary tract infection—Temozolomide—melanoma	0.00234	0.00528	CcSEcCtD
Treprostinil—Cardiac failure congestive—Docetaxel—melanoma	0.00229	0.00517	CcSEcCtD
Treprostinil—Sinusitis—Temozolomide—melanoma	0.00226	0.0051	CcSEcCtD
Treprostinil—Haemoglobin—Carmustine—melanoma	0.00225	0.00508	CcSEcCtD
Treprostinil—Haemorrhage—Carmustine—melanoma	0.00224	0.00505	CcSEcCtD
Treprostinil—Erythema—Bleomycin—melanoma	0.00223	0.00504	CcSEcCtD
Treprostinil—Flushing—Dactinomycin—melanoma	0.00222	0.00501	CcSEcCtD
Treprostinil—Oedema peripheral—Carmustine—melanoma	0.00221	0.00498	CcSEcCtD
Treprostinil—Haemoglobin—Temozolomide—melanoma	0.00217	0.00491	CcSEcCtD
Treprostinil—Haemorrhage—Temozolomide—melanoma	0.00216	0.00488	CcSEcCtD
Treprostinil—Asthenia—Vemurafenib—melanoma	0.00216	0.00487	CcSEcCtD
Treprostinil—Pharyngitis—Temozolomide—melanoma	0.00215	0.00484	CcSEcCtD
Treprostinil—Oedema peripheral—Temozolomide—melanoma	0.00213	0.00481	CcSEcCtD
Treprostinil—Cardiac failure—Docetaxel—melanoma	0.00213	0.00481	CcSEcCtD
Treprostinil—Pruritus—Vemurafenib—melanoma	0.00213	0.0048	CcSEcCtD
Treprostinil—Erythema—Dactinomycin—melanoma	0.00208	0.0047	CcSEcCtD
Treprostinil—Pain in extremity—Docetaxel—melanoma	0.00208	0.00469	CcSEcCtD
Treprostinil—Flushing—Carmustine—melanoma	0.00208	0.00469	CcSEcCtD
Treprostinil—Ill-defined disorder—Bleomycin—melanoma	0.00207	0.00467	CcSEcCtD
Treprostinil—Anaemia—Bleomycin—melanoma	0.00206	0.00466	CcSEcCtD
Treprostinil—Diarrhoea—Vemurafenib—melanoma	0.00206	0.00464	CcSEcCtD
Treprostinil—Malaise—Bleomycin—melanoma	0.00201	0.00454	CcSEcCtD
Treprostinil—Flushing—Temozolomide—melanoma	0.00201	0.00453	CcSEcCtD
Treprostinil—Dizziness—Vemurafenib—melanoma	0.00199	0.00449	CcSEcCtD
Treprostinil—Erythema—Carmustine—melanoma	0.00195	0.0044	CcSEcCtD
Treprostinil—Cough—Bleomycin—melanoma	0.00195	0.0044	CcSEcCtD
Treprostinil—Dehydration—Docetaxel—melanoma	0.00193	0.00436	CcSEcCtD
Treprostinil—Ill-defined disorder—Dactinomycin—melanoma	0.00193	0.00436	CcSEcCtD
Treprostinil—Anaemia—Dactinomycin—melanoma	0.00192	0.00434	CcSEcCtD
Treprostinil—Vomiting—Vemurafenib—melanoma	0.00191	0.00431	CcSEcCtD
Treprostinil—Chest pain—Bleomycin—melanoma	0.0019	0.00429	CcSEcCtD
Treprostinil—Myalgia—Bleomycin—melanoma	0.0019	0.00429	CcSEcCtD
Treprostinil—Rash—Vemurafenib—melanoma	0.0019	0.00428	CcSEcCtD
Treprostinil—Dermatitis—Vemurafenib—melanoma	0.00189	0.00427	CcSEcCtD
Treprostinil—Back pain—Carmustine—melanoma	0.00189	0.00425	CcSEcCtD
Treprostinil—Headache—Vemurafenib—melanoma	0.00188	0.00425	CcSEcCtD
Treprostinil—Erythema—Temozolomide—melanoma	0.00188	0.00425	CcSEcCtD
Treprostinil—Discomfort—Bleomycin—melanoma	0.00188	0.00424	CcSEcCtD
Treprostinil—Malaise—Dactinomycin—melanoma	0.00188	0.00424	CcSEcCtD
Treprostinil—Oedema—Bleomycin—melanoma	0.00182	0.00411	CcSEcCtD
Treprostinil—Back pain—Temozolomide—melanoma	0.00182	0.00411	CcSEcCtD
Treprostinil—Infection—Bleomycin—melanoma	0.00181	0.00408	CcSEcCtD
Treprostinil—Anaemia—Carmustine—melanoma	0.0018	0.00406	CcSEcCtD
Treprostinil—Nausea—Vemurafenib—melanoma	0.00179	0.00403	CcSEcCtD
Treprostinil—Thrombocytopenia—Bleomycin—melanoma	0.00178	0.00402	CcSEcCtD
Treprostinil—Myalgia—Dactinomycin—melanoma	0.00177	0.004	CcSEcCtD
Treprostinil—Discomfort—Dactinomycin—melanoma	0.00175	0.00395	CcSEcCtD
Treprostinil—Ill-defined disorder—Temozolomide—melanoma	0.00175	0.00394	CcSEcCtD
Treprostinil—Anaemia—Temozolomide—melanoma	0.00174	0.00393	CcSEcCtD
Treprostinil—Anorexia—Bleomycin—melanoma	0.00174	0.00392	CcSEcCtD
Treprostinil—Angioedema—Temozolomide—melanoma	0.00172	0.00388	CcSEcCtD
Treprostinil—Hypotension—Bleomycin—melanoma	0.0017	0.00384	CcSEcCtD
Treprostinil—Oedema—Dactinomycin—melanoma	0.0017	0.00383	CcSEcCtD
Treprostinil—Malaise—Temozolomide—melanoma	0.0017	0.00383	CcSEcCtD
Treprostinil—Infection—Dactinomycin—melanoma	0.00169	0.00381	CcSEcCtD
Treprostinil—Palpitations—Temozolomide—melanoma	0.00166	0.00375	CcSEcCtD
Treprostinil—Thrombocytopenia—Dactinomycin—melanoma	0.00166	0.00375	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Bleomycin—melanoma	0.00166	0.00375	CcSEcCtD
Treprostinil—Chest pain—Carmustine—melanoma	0.00166	0.00374	CcSEcCtD
Treprostinil—Myalgia—Carmustine—melanoma	0.00166	0.00374	CcSEcCtD
Treprostinil—Anxiety—Carmustine—melanoma	0.00165	0.00373	CcSEcCtD
Treprostinil—Cough—Temozolomide—melanoma	0.00164	0.00371	CcSEcCtD
Treprostinil—Paraesthesia—Bleomycin—melanoma	0.00164	0.00369	CcSEcCtD
Treprostinil—Dyspnoea—Bleomycin—melanoma	0.00162	0.00366	CcSEcCtD
Treprostinil—Anorexia—Dactinomycin—melanoma	0.00162	0.00365	CcSEcCtD
Treprostinil—Pneumonia—Docetaxel—melanoma	0.00161	0.00364	CcSEcCtD
Treprostinil—Myalgia—Temozolomide—melanoma	0.0016	0.00362	CcSEcCtD
Treprostinil—Arthralgia—Temozolomide—melanoma	0.0016	0.00362	CcSEcCtD
Treprostinil—Anxiety—Temozolomide—melanoma	0.0016	0.0036	CcSEcCtD
Treprostinil—Oedema—Carmustine—melanoma	0.00159	0.00359	CcSEcCtD
Treprostinil—Discomfort—Temozolomide—melanoma	0.00158	0.00357	CcSEcCtD
Treprostinil—Decreased appetite—Bleomycin—melanoma	0.00158	0.00357	CcSEcCtD
Treprostinil—Infection—Carmustine—melanoma	0.00158	0.00356	CcSEcCtD
Treprostinil—Pain—Bleomycin—melanoma	0.00156	0.00352	CcSEcCtD
Treprostinil—Thrombocytopenia—Carmustine—melanoma	0.00156	0.00351	CcSEcCtD
Treprostinil—Tachycardia—Carmustine—melanoma	0.00155	0.0035	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00155	0.00349	CcSEcCtD
Treprostinil—Oedema—Temozolomide—melanoma	0.00154	0.00347	CcSEcCtD
Treprostinil—Infection—Temozolomide—melanoma	0.00153	0.00344	CcSEcCtD
Treprostinil—Anorexia—Carmustine—melanoma	0.00152	0.00342	CcSEcCtD
Treprostinil—Epistaxis—Docetaxel—melanoma	0.00151	0.00341	CcSEcCtD
Treprostinil—Thrombocytopenia—Temozolomide—melanoma	0.00151	0.0034	CcSEcCtD
Treprostinil—Feeling abnormal—Bleomycin—melanoma	0.0015	0.00339	CcSEcCtD
Treprostinil—Hypotension—Carmustine—melanoma	0.00149	0.00335	CcSEcCtD
Treprostinil—Decreased appetite—Dactinomycin—melanoma	0.00148	0.00333	CcSEcCtD
Treprostinil—Fatigue—Dactinomycin—melanoma	0.00147	0.00331	CcSEcCtD
Treprostinil—Anorexia—Temozolomide—melanoma	0.00147	0.00331	CcSEcCtD
Treprostinil—Pain—Dactinomycin—melanoma	0.00145	0.00328	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Carmustine—melanoma	0.00145	0.00327	CcSEcCtD
Treprostinil—Haemoglobin—Docetaxel—melanoma	0.00145	0.00326	CcSEcCtD
Treprostinil—Rhinitis—Docetaxel—melanoma	0.00144	0.00325	CcSEcCtD
Treprostinil—Body temperature increased—Bleomycin—melanoma	0.00144	0.00325	CcSEcCtD
Treprostinil—Haemorrhage—Docetaxel—melanoma	0.00144	0.00325	CcSEcCtD
Treprostinil—Insomnia—Carmustine—melanoma	0.00144	0.00325	CcSEcCtD
Treprostinil—Paraesthesia—Carmustine—melanoma	0.00143	0.00322	CcSEcCtD
Treprostinil—Pharyngitis—Docetaxel—melanoma	0.00143	0.00322	CcSEcCtD
Treprostinil—Dyspnoea—Carmustine—melanoma	0.00142	0.0032	CcSEcCtD
Treprostinil—Oedema peripheral—Docetaxel—melanoma	0.00142	0.0032	CcSEcCtD
Treprostinil—Feeling abnormal—Dactinomycin—melanoma	0.0014	0.00316	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Temozolomide—melanoma	0.0014	0.00316	CcSEcCtD
Treprostinil—Insomnia—Temozolomide—melanoma	0.00139	0.00314	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—melanoma	0.00139	0.00313	CcSEcCtD
Treprostinil—Decreased appetite—Carmustine—melanoma	0.00138	0.00312	CcSEcCtD
Treprostinil—Paraesthesia—Temozolomide—melanoma	0.00138	0.00311	CcSEcCtD
Treprostinil—Dyspnoea—Temozolomide—melanoma	0.00137	0.00309	CcSEcCtD
Treprostinil—Pain—Carmustine—melanoma	0.00136	0.00307	CcSEcCtD
Treprostinil—Dyspepsia—Temozolomide—melanoma	0.00135	0.00305	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—melanoma	0.00134	0.00303	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—melanoma	0.00134	0.00303	CcSEcCtD
Treprostinil—Decreased appetite—Temozolomide—melanoma	0.00134	0.00301	CcSEcCtD
Treprostinil—Flushing—Docetaxel—melanoma	0.00134	0.00301	CcSEcCtD
Treprostinil—Fatigue—Temozolomide—melanoma	0.00133	0.00299	CcSEcCtD
Treprostinil—Pain—Temozolomide—melanoma	0.00131	0.00297	CcSEcCtD
Treprostinil—Feeling abnormal—Carmustine—melanoma	0.00131	0.00296	CcSEcCtD
Treprostinil—Asthenia—Bleomycin—melanoma	0.00131	0.00295	CcSEcCtD
Treprostinil—Gastrointestinal pain—Carmustine—melanoma	0.0013	0.00293	CcSEcCtD
Treprostinil—Pruritus—Bleomycin—melanoma	0.00129	0.00291	CcSEcCtD
Treprostinil—Feeling abnormal—Temozolomide—melanoma	0.00127	0.00286	CcSEcCtD
Treprostinil—Abdominal pain—Carmustine—melanoma	0.00126	0.00284	CcSEcCtD
Treprostinil—Body temperature increased—Carmustine—melanoma	0.00126	0.00284	CcSEcCtD
Treprostinil—Gastrointestinal pain—Temozolomide—melanoma	0.00126	0.00284	CcSEcCtD
Treprostinil—Erythema—Docetaxel—melanoma	0.00125	0.00283	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—melanoma	0.00122	0.00275	CcSEcCtD
Treprostinil—Abdominal pain—Temozolomide—melanoma	0.00122	0.00274	CcSEcCtD
Treprostinil—Body temperature increased—Temozolomide—melanoma	0.00122	0.00274	CcSEcCtD
Treprostinil—Back pain—Docetaxel—melanoma	0.00121	0.00273	CcSEcCtD
Treprostinil—Muscle spasms—Docetaxel—melanoma	0.0012	0.00272	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—melanoma	0.00116	0.00262	CcSEcCtD
Treprostinil—Vomiting—Bleomycin—melanoma	0.00116	0.00261	CcSEcCtD
Treprostinil—Anaemia—Docetaxel—melanoma	0.00116	0.00261	CcSEcCtD
Treprostinil—Rash—Bleomycin—melanoma	0.00115	0.00259	CcSEcCtD
Treprostinil—Dermatitis—Bleomycin—melanoma	0.00115	0.00259	CcSEcCtD
Treprostinil—Asthenia—Carmustine—melanoma	0.00114	0.00257	CcSEcCtD
Treprostinil—Syncope—Docetaxel—melanoma	0.00112	0.00253	CcSEcCtD
Treprostinil—Palpitations—Docetaxel—melanoma	0.00111	0.0025	CcSEcCtD
Treprostinil—Asthenia—Temozolomide—melanoma	0.0011	0.00249	CcSEcCtD
Treprostinil—Loss of consciousness—Docetaxel—melanoma	0.0011	0.00248	CcSEcCtD
Treprostinil—Cough—Docetaxel—melanoma	0.00109	0.00247	CcSEcCtD
Treprostinil—Diarrhoea—Carmustine—melanoma	0.00109	0.00246	CcSEcCtD
Treprostinil—Pruritus—Temozolomide—melanoma	0.00109	0.00245	CcSEcCtD
Treprostinil—Nausea—Bleomycin—melanoma	0.00108	0.00244	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—melanoma	0.00108	0.00244	CcSEcCtD
Treprostinil—Rash—Dactinomycin—melanoma	0.00107	0.00242	CcSEcCtD
Treprostinil—Arthralgia—Docetaxel—melanoma	0.00107	0.00241	CcSEcCtD
Treprostinil—Chest pain—Docetaxel—melanoma	0.00107	0.00241	CcSEcCtD
Treprostinil—Myalgia—Docetaxel—melanoma	0.00107	0.00241	CcSEcCtD
Treprostinil—Dizziness—Carmustine—melanoma	0.00105	0.00237	CcSEcCtD
Treprostinil—Diarrhoea—Temozolomide—melanoma	0.00105	0.00237	CcSEcCtD
Treprostinil—Oedema—Docetaxel—melanoma	0.00102	0.00231	CcSEcCtD
Treprostinil—Dizziness—Temozolomide—melanoma	0.00102	0.00229	CcSEcCtD
Treprostinil—Infection—Docetaxel—melanoma	0.00102	0.00229	CcSEcCtD
Treprostinil—Vomiting—Carmustine—melanoma	0.00101	0.00228	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—melanoma	0.00101	0.00228	CcSEcCtD
Treprostinil—Shock—Docetaxel—melanoma	0.00101	0.00227	CcSEcCtD
Treprostinil—Rash—Carmustine—melanoma	0.001	0.00226	CcSEcCtD
Treprostinil—Dermatitis—Carmustine—melanoma	0.001	0.00226	CcSEcCtD
Treprostinil—Thrombocytopenia—Docetaxel—melanoma	0.001	0.00226	CcSEcCtD
Treprostinil—Tachycardia—Docetaxel—melanoma	0.000998	0.00225	CcSEcCtD
Treprostinil—Headache—Carmustine—melanoma	0.000997	0.00225	CcSEcCtD
Treprostinil—Vomiting—Temozolomide—melanoma	0.000977	0.0022	CcSEcCtD
Treprostinil—Anorexia—Docetaxel—melanoma	0.000975	0.0022	CcSEcCtD
Treprostinil—Rash—Temozolomide—melanoma	0.000969	0.00219	CcSEcCtD
Treprostinil—Dermatitis—Temozolomide—melanoma	0.000968	0.00218	CcSEcCtD
Treprostinil—Headache—Temozolomide—melanoma	0.000963	0.00217	CcSEcCtD
Treprostinil—Hypotension—Docetaxel—melanoma	0.000955	0.00215	CcSEcCtD
Treprostinil—Nausea—Carmustine—melanoma	0.000945	0.00213	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000931	0.0021	CcSEcCtD
Treprostinil—Insomnia—Docetaxel—melanoma	0.000925	0.00209	CcSEcCtD
Treprostinil—Paraesthesia—Docetaxel—melanoma	0.000918	0.00207	CcSEcCtD
Treprostinil—Nausea—Temozolomide—melanoma	0.000913	0.00206	CcSEcCtD
Treprostinil—Dyspnoea—Docetaxel—melanoma	0.000911	0.00206	CcSEcCtD
Treprostinil—Dyspepsia—Docetaxel—melanoma	0.0009	0.00203	CcSEcCtD
Treprostinil—Decreased appetite—Docetaxel—melanoma	0.000889	0.002	CcSEcCtD
Treprostinil—Fatigue—Docetaxel—melanoma	0.000881	0.00199	CcSEcCtD
Treprostinil—Pain—Docetaxel—melanoma	0.000874	0.00197	CcSEcCtD
Treprostinil—Feeling abnormal—Docetaxel—melanoma	0.000842	0.0019	CcSEcCtD
Treprostinil—Gastrointestinal pain—Docetaxel—melanoma	0.000836	0.00189	CcSEcCtD
Treprostinil—Abdominal pain—Docetaxel—melanoma	0.000808	0.00182	CcSEcCtD
Treprostinil—Body temperature increased—Docetaxel—melanoma	0.000808	0.00182	CcSEcCtD
Treprostinil—Asthenia—Docetaxel—melanoma	0.000734	0.00165	CcSEcCtD
Treprostinil—Pruritus—Docetaxel—melanoma	0.000723	0.00163	CcSEcCtD
Treprostinil—Diarrhoea—Docetaxel—melanoma	0.000699	0.00158	CcSEcCtD
Treprostinil—Dizziness—Docetaxel—melanoma	0.000676	0.00152	CcSEcCtD
Treprostinil—Vomiting—Docetaxel—melanoma	0.00065	0.00147	CcSEcCtD
Treprostinil—Rash—Docetaxel—melanoma	0.000645	0.00145	CcSEcCtD
Treprostinil—Dermatitis—Docetaxel—melanoma	0.000644	0.00145	CcSEcCtD
Treprostinil—Headache—Docetaxel—melanoma	0.00064	0.00144	CcSEcCtD
Treprostinil—Nausea—Docetaxel—melanoma	0.000607	0.00137	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CG—melanoma	0.000202	0.000364	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.0002	0.000359	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CG—melanoma	0.0002	0.000359	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—melanoma	0.000198	0.000355	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK3—melanoma	0.000197	0.000354	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SYK—melanoma	0.000195	0.00035	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CD—melanoma	0.000193	0.000347	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO4—melanoma	0.000193	0.000347	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HDAC2—melanoma	0.000193	0.000347	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR4—melanoma	0.000193	0.000347	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—melanoma	0.000192	0.000344	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT3—melanoma	0.000191	0.000344	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ITGAV—melanoma	0.000191	0.000344	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGFR—melanoma	0.000191	0.000344	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNAQ—melanoma	0.000191	0.000343	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—melanoma	0.000189	0.00034	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACER3—melanoma	0.000188	0.000338	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NOTCH1—melanoma	0.000188	0.000337	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK1—melanoma	0.000187	0.000337	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—melanoma	0.000184	0.00033	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PRKCA—melanoma	0.000182	0.000327	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—melanoma	0.000181	0.000326	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ERCC2—melanoma	0.000181	0.000324	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SYK—melanoma	0.000179	0.000322	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CD—melanoma	0.000178	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOCS1—melanoma	0.000177	0.000318	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—melanoma	0.000177	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—melanoma	0.000177	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAP2K1—melanoma	0.000177	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—S100B—melanoma	0.000177	0.000317	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGFR—melanoma	0.000176	0.000316	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ITGAV—melanoma	0.000176	0.000316	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT3—melanoma	0.000176	0.000316	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CD—melanoma	0.000176	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK1—melanoma	0.000172	0.00031	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UGT2B10—melanoma	0.000172	0.000309	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00017	0.000305	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB4—melanoma	0.000169	0.000304	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CB—melanoma	0.000169	0.000303	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN2B—melanoma	0.000168	0.000301	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SOCS1—melanoma	0.000163	0.000293	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—melanoma	0.000163	0.000293	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAP2K1—melanoma	0.000163	0.000292	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—S100B—melanoma	0.000163	0.000292	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—melanoma	0.000163	0.000292	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD86—melanoma	0.000162	0.000291	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—melanoma	0.000162	0.000291	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—melanoma	0.000162	0.00029	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—melanoma	0.000161	0.000289	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HS3ST5—melanoma	0.00016	0.000288	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—melanoma	0.000157	0.000283	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CSF2—melanoma	0.000157	0.000282	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF1—melanoma	0.000157	0.000282	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB4—melanoma	0.000156	0.000279	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—melanoma	0.000155	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—melanoma	0.000155	0.000278	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN2B—melanoma	0.000154	0.000277	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—E2F1—melanoma	0.000154	0.000276	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—melanoma	0.000153	0.000275	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFRA—melanoma	0.000152	0.000273	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ITGB3—melanoma	0.000151	0.000271	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCA—melanoma	0.000151	0.000271	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—melanoma	0.00015	0.00027	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—melanoma	0.00015	0.000269	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.00015	0.000269	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD86—melanoma	0.000149	0.000268	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—melanoma	0.000149	0.000268	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—melanoma	0.000148	0.000266	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—melanoma	0.000148	0.000265	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAP2K2—melanoma	0.000147	0.000265	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—melanoma	0.000147	0.000264	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—melanoma	0.000145	0.00026	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CSF2—melanoma	0.000145	0.00026	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF1—melanoma	0.000145	0.00026	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—melanoma	0.000143	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—melanoma	0.000142	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—E2F1—melanoma	0.000142	0.000254	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—melanoma	0.000141	0.000253	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—melanoma	0.000141	0.000253	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFRA—melanoma	0.00014	0.000252	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—melanoma	0.00014	0.000252	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAC1—melanoma	0.00014	0.000251	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ITGB3—melanoma	0.000139	0.000249	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCA—melanoma	0.000139	0.000249	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—melanoma	0.000138	0.000249	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—melanoma	0.000138	0.000247	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—melanoma	0.000136	0.000244	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAP2K2—melanoma	0.000136	0.000243	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—melanoma	0.000135	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—melanoma	0.000134	0.000241	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—melanoma	0.000133	0.000239	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—melanoma	0.000129	0.000232	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—melanoma	0.000129	0.000232	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000129	0.000231	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAC1—melanoma	0.000129	0.000231	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—melanoma	0.000128	0.00023	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—melanoma	0.000125	0.000225	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—melanoma	0.000124	0.000222	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FN1—melanoma	0.000123	0.000221	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—melanoma	0.000123	0.000221	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—melanoma	0.000122	0.00022	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCB4—melanoma	0.000121	0.000218	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH1—melanoma	0.000121	0.000217	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000119	0.000214	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD80—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—melanoma	0.000118	0.000212	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGF—melanoma	0.000117	0.00021	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC6A11—melanoma	0.000114	0.000205	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIP4K2A—melanoma	0.000114	0.000205	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FN1—melanoma	0.000113	0.000204	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—melanoma	0.000113	0.000203	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH1—melanoma	0.000111	0.000199	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTAP—melanoma	0.000111	0.000199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—melanoma	0.000111	0.000199	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—melanoma	0.000109	0.000196	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD80—melanoma	0.000109	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—melanoma	0.000109	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—melanoma	0.000109	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—melanoma	0.000109	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—melanoma	0.000109	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000108	0.000195	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—melanoma	0.000108	0.000194	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—melanoma	0.000108	0.000194	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—melanoma	0.000108	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—melanoma	0.000108	0.000193	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGF—melanoma	0.000107	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAP2K1—melanoma	0.000104	0.000188	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—melanoma	0.000104	0.000187	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—melanoma	0.000104	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—melanoma	0.000104	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—melanoma	0.000103	0.000185	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—melanoma	0.000102	0.000183	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—melanoma	0.000102	0.000182	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—melanoma	0.000101	0.000181	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—melanoma	9.94e-05	0.000179	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF2—melanoma	9.93e-05	0.000178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—melanoma	9.9e-05	0.000178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—melanoma	9.89e-05	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LUM—melanoma	9.89e-05	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PHGDH—melanoma	9.89e-05	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HPSE—melanoma	9.7e-05	0.000174	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAP2K1—melanoma	9.61e-05	0.000173	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—melanoma	9.55e-05	0.000171	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CUBN—melanoma	9.52e-05	0.000171	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—melanoma	9.46e-05	0.00017	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—melanoma	9.44e-05	0.00017	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—melanoma	9.35e-05	0.000168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—melanoma	9.33e-05	0.000168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MDM2—melanoma	9.29e-05	0.000167	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDHD—melanoma	9.19e-05	0.000165	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CSPG4—melanoma	9.19e-05	0.000165	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BSG—melanoma	9.19e-05	0.000165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—melanoma	9.16e-05	0.000165	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF2—melanoma	9.14e-05	0.000164	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—melanoma	9.04e-05	0.000162	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPAM—melanoma	8.9e-05	0.00016	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—melanoma	8.69e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—melanoma	8.63e-05	0.000155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—melanoma	8.59e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MDM2—melanoma	8.55e-05	0.000154	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—melanoma	8.49e-05	0.000152	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—melanoma	8.43e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—melanoma	8.39e-05	0.000151	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—melanoma	8.32e-05	0.000149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—melanoma	8.32e-05	0.000149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—melanoma	8.3e-05	0.000149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—melanoma	8.26e-05	0.000148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—melanoma	8.09e-05	0.000145	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—melanoma	8.02e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—melanoma	8e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—melanoma	7.94e-05	0.000143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—melanoma	7.86e-05	0.000141	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—melanoma	7.83e-05	0.000141	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—melanoma	7.81e-05	0.00014	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—melanoma	7.81e-05	0.00014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKB1—melanoma	7.78e-05	0.00014	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—melanoma	7.72e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—melanoma	7.65e-05	0.000137	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—melanoma	7.64e-05	0.000137	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—melanoma	7.62e-05	0.000137	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—melanoma	7.6e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G6—melanoma	7.57e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—melanoma	7.45e-05	0.000134	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—melanoma	7.38e-05	0.000133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—melanoma	7.23e-05	0.00013	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—melanoma	7.21e-05	0.000129	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—melanoma	7.19e-05	0.000129	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKB1—melanoma	7.16e-05	0.000129	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—melanoma	7.06e-05	0.000127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—melanoma	7.01e-05	0.000126	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—melanoma	7e-05	0.000126	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—melanoma	6.99e-05	0.000126	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—melanoma	6.97e-05	0.000125	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—VCAN—melanoma	6.8e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—melanoma	6.68e-05	0.00012	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—melanoma	6.66e-05	0.00012	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—melanoma	6.49e-05	0.000117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—melanoma	6.49e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.44e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—melanoma	6.43e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—melanoma	6.41e-05	0.000115	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—melanoma	6.35e-05	0.000114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—melanoma	6.35e-05	0.000114	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.21e-05	0.000112	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—melanoma	6.14e-05	0.00011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—melanoma	6e-05	0.000108	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—melanoma	5.98e-05	0.000107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—melanoma	5.85e-05	0.000105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—melanoma	5.84e-05	0.000105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP17A1—melanoma	5.74e-05	0.000103	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.66e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	5.59e-05	0.0001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—melanoma	5.52e-05	9.92e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—melanoma	5.51e-05	9.9e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—melanoma	5.44e-05	9.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNA11—melanoma	5.42e-05	9.73e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—melanoma	5.33e-05	9.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FASN—melanoma	5.3e-05	9.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A5—melanoma	5.22e-05	9.37e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—melanoma	5.1e-05	9.16e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—melanoma	5.07e-05	9.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAQ—melanoma	5.04e-05	9.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD44—melanoma	5.04e-05	9.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.93e-05	8.86e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—melanoma	4.91e-05	8.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.89e-05	8.78e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—melanoma	4.88e-05	8.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1B1—melanoma	4.83e-05	8.68e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—melanoma	4.69e-05	8.43e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—melanoma	4.5e-05	8.09e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—melanoma	4.49e-05	8.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.26e-05	7.66e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—melanoma	4.14e-05	7.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—melanoma	3.98e-05	7.15e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PRKCA—melanoma	3.66e-05	6.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ERCC2—melanoma	3.63e-05	6.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.01e-05	5.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—melanoma	2.87e-05	5.15e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—melanoma	2.77e-05	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—melanoma	2.52e-05	4.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—melanoma	2.49e-05	4.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—melanoma	2.2e-05	3.95e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—melanoma	2.18e-05	3.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—melanoma	1.9e-05	3.41e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—melanoma	1.34e-05	2.41e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—melanoma	1.09e-05	1.97e-05	CbGpPWpGaD
